BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Z, Li Y, Yang X, Pan W, Pan H. The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles. Pharmacol Res 2017;126:84-96. [PMID: 28734999 DOI: 10.1016/j.phrs.2017.07.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Safwat S, Hathout RM, Ishak RA, Mortada ND. Elaborated survey in the scope of nanocarriers engineering for boosting chemotherapy cytotoxicity: A meta-analysis study. Int J Pharm 2021;610:121268. [PMID: 34748812 DOI: 10.1016/j.ijpharm.2021.121268] [Reference Citation Analysis]
2 Misiak P, Markiewicz KH, Szymczuk D, Wilczewska AZ. Polymeric Drug Delivery Systems Bearing Cholesterol Moieties: A Review. Polymers (Basel) 2020;12:E2620. [PMID: 33172152 DOI: 10.3390/polym12112620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu Z, Pan H, Li Y, Pan W. Evaluation of the Synergism Mechanism of Tamoxifen and Docetaxel by Nanoparticles. Anticancer Agents Med Chem 2019;19:1991-2000. [PMID: 31267877 DOI: 10.2174/1871520619666190702120829] [Reference Citation Analysis]
4 Sakurai Y, Harashima H. Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 2019;16:915-36. [DOI: 10.1080/17425247.2019.1645115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Manivannan S, Nagaraj S, Narayan S. A Reflection on the Mechanism of the Role of Nanoparticles in Increasing the Efficacy of Anti-tumour Properties of Docetaxel. Curr Pathobiol Rep 2021;9:79-91. [DOI: 10.1007/s40139-021-00223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kabir A, Nazeer N, Bissessur R, Ahmed M. Diatoms embedded, self-assembled carriers for dual delivery of chemotherapeutics in cancer cell lines. Int J Pharm 2020;573:118887. [PMID: 31765771 DOI: 10.1016/j.ijpharm.2019.118887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Meng D, Lei M, Han Y, Zhao D, Zhang X, Yang Y, Liu R. MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells. Onco Targets Ther 2018;11:7733-43. [PMID: 30464522 DOI: 10.2147/OTT.S187221] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
8 Tramontano C, Chianese G, Terracciano M, de Stefano L, Rea I. Nanostructured Biosilica of Diatoms: From Water World to Biomedical Applications. Applied Sciences 2020;10:6811. [DOI: 10.3390/app10196811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 da Fonseca TG, Abessa DMS, Bebianno MJ. Effects of mixtures of anticancer drugs in the benthic polychaete Nereis diversicolor. Environ Pollut 2019;252:1180-92. [PMID: 31252116 DOI: 10.1016/j.envpol.2019.05.095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
10 Gao M, Deng H, Zhang W. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy. Curr Top Med Chem 2021;21:126-39. [PMID: 32962617 DOI: 10.2174/1568026620666200922113846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Du X, Yin S, Zhou F, Du X, Xu J, Gu X, Wang G, Li J. Reduction-sensitive mixed micelles for selective intracellular drug delivery to tumor cells and reversal of multidrug resistance. International Journal of Pharmaceutics 2018;550:1-13. [DOI: 10.1016/j.ijpharm.2018.08.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
12 Tan H, Liu Y, Hou N, Cui S, Liu B, Fan S, Yu G, Han C, Zheng D, Li W, Liu Y, Xu B, Wang Z, Cui D. Tumor Microenvironment pH-Responsive Pentagonal Gold Prism-Based Nanoplatform for Multimodal Imaging and Combined Therapy of Castration-Resistant Prostate Cancer. Acta Biomater 2022:S1742-7061(22)00011-3. [PMID: 35032718 DOI: 10.1016/j.actbio.2022.01.012] [Reference Citation Analysis]
13 Cai J, Fu J, Li R, Zhang F, Ling G, Zhang P. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles. Carbohydr Polym 2019;208:356-64. [PMID: 30658811 DOI: 10.1016/j.carbpol.2018.12.074] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
14 Jiang G, Huang Z, Yuan Y, Tao K, Feng W. Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells. J Hematol Oncol 2021;14:139. [PMID: 34488814 DOI: 10.1186/s13045-021-01150-x] [Reference Citation Analysis]
15 Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018;16:71. [PMID: 30231877 DOI: 10.1186/s12951-018-0392-8] [Cited by in Crossref: 1010] [Cited by in F6Publishing: 735] [Article Influence: 252.5] [Reference Citation Analysis]
16 Lu X, Fang M, Yang Y, Dai Y, Xu J, Zhao D, Lu Y, Chen X, Lu S, Li N. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy. Drug Deliv and Transl Res 2020;10:122-35. [DOI: 10.1007/s13346-019-00667-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
17 Jeevanandam J, Kulabhusan PK, Sabbih G, Akram M, Danquah MK. Phytosynthesized nanoparticles as a potential cancer therapeutic agent. 3 Biotech 2020;10:535. [PMID: 33224704 DOI: 10.1007/s13205-020-02516-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zamani M, Aghajanzadeh M, Rostamizadeh K, Kheiri Manjili H, Fridoni M, Danafar H. In vivo study of poly (ethylene glycol)-poly (caprolactone)-modified folic acid nanocarriers as a pH responsive system for tumor-targeted co-delivery of tamoxifen and quercetin. Journal of Drug Delivery Science and Technology 2019;54:101283. [DOI: 10.1016/j.jddst.2019.101283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Hussein HA, Abdullah MA. Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment. Appl Nanosci. [DOI: 10.1007/s13204-021-02018-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lei M, Ma G, Sha S, Wang X, Feng H, Zhu Y, Du X. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Drug Deliv 2019;26:262-72. [PMID: 30856352 DOI: 10.1080/10717544.2019.1580797] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
21 Meng D, Lei H, Zheng X, Han Y, Sun R, Zhao D, Liu R. A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells. Onco Targets Ther 2019;12:3919-31. [PMID: 31213826 DOI: 10.2147/OTT.S201421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
22 Du X, Yin S, Wang Y, Gu X, Wang G, Li J. Hyaluronic acid-functionalized half-generation of sectorial dendrimers for anticancer drug delivery and enhanced biocompatibility. Carbohydrate Polymers 2018;202:513-22. [DOI: 10.1016/j.carbpol.2018.09.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]